Osterweis Capital Management Inc. Has $5.55 Million Holdings in Transcat, Inc. $TRNS

Key Points

• Osterweis Capital Management Inc. has reduced its position in Transcat, Inc. by 16.7%, selling 14,982 shares to now hold 74,483 shares valued at approximately $5.55 million.
• Institutional investors own approximately 98.34% of Transcat's stock, with several major funds significantly increasing their positions in the company recently.
• Transcat reported earnings of $0.59 per share for the most recent quarter, surpassing analysts’ expectations and leading to a consensus rating of "Moderate Buy" among investment analysts.

Osterweis Capital Management Inc. lowered its holdings in Transcat, Inc. (NASDAQ:TRNS - Free Report) by 16.7% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 74,483 shares of the scientific and technical instruments company's stock after selling 14,982 shares during the quarter. Osterweis Capital Management Inc. owned 0.80% of Transcat worth $5,545,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of TRNS. Royal Bank of Canada boosted its position in shares of Transcat by 328.4% in the fourth quarter. Royal Bank of Canada now owns 173,514 shares of the scientific and technical instruments company's stock valued at $18,348,000 after acquiring an additional 133,013 shares during the period. T. Rowe Price Investment Management Inc. grew its position in Transcat by 17.1% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 607,360 shares of the scientific and technical instruments company's stock worth $45,218,000 after purchasing an additional 88,763 shares during the last quarter. Bessemer Group Inc. increased its holdings in shares of Transcat by 64.3% during the 1st quarter. Bessemer Group Inc. now owns 180,069 shares of the scientific and technical instruments company's stock worth $13,404,000 after purchasing an additional 70,461 shares during the period. Conestoga Capital Advisors LLC raised its position in shares of Transcat by 5.8% during the first quarter. Conestoga Capital Advisors LLC now owns 957,254 shares of the scientific and technical instruments company's stock valued at $71,268,000 after buying an additional 52,328 shares during the last quarter. Finally, Neuberger Berman Group LLC lifted its stake in shares of Transcat by 5.5% in the first quarter. Neuberger Berman Group LLC now owns 921,898 shares of the scientific and technical instruments company's stock valued at $68,635,000 after buying an additional 47,913 shares during the period. 98.34% of the stock is currently owned by institutional investors and hedge funds.

Transcat Price Performance

Shares of NASDAQ TRNS traded up $1.34 during mid-day trading on Wednesday, hitting $73.25. 37,181 shares of the stock were exchanged, compared to its average volume of 106,593. Transcat, Inc. has a twelve month low of $67.56 and a twelve month high of $133.72. The stock's fifty day simple moving average is $81.31 and its two-hundred day simple moving average is $80.48. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.36 and a current ratio of 2.92. The company has a market cap of $682.69 million, a P/E ratio of 51.57 and a beta of 0.72.

Transcat (NASDAQ:TRNS - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The scientific and technical instruments company reported $0.59 earnings per share for the quarter, beating analysts' consensus estimates of $0.40 by $0.19. Transcat had a return on equity of 6.66% and a net margin of 4.64%.The firm had revenue of $76.42 million during the quarter, compared to analysts' expectations of $72.28 million. As a group, analysts forecast that Transcat, Inc. will post 2.3 EPS for the current fiscal year.

Wall Street Analyst Weigh In

TRNS has been the topic of several research reports. HC Wainwright restated a "buy" rating and set a $116.00 price target on shares of Transcat in a research note on Friday, August 22nd. Wall Street Zen upgraded Transcat from a "sell" rating to a "hold" rating in a research note on Wednesday, May 28th. Finally, Lake Street Capital assumed coverage on shares of Transcat in a research note on Thursday, July 10th. They set a "buy" rating and a $105.00 price target on the stock. Three investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $112.20.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.